HER2 Support Group Forums - View Single Post - Exelixis commences cabozantinib phase 3 pivotal trial in mCRPC

News · 05-30-2012, 09:30 PM

Exelixis, Inc. today announced the initiation of COMET-1, a phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer.

More...

05-30-2012, 09:30 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,109	Exelixis commences cabozantinib phase 3 pivotal trial in mCRPC Exelixis, Inc. today announced the initiation of COMET-1, a phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer. More...